Nutritional modulation of the intestinal microbiota: future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease
Year Published: 2018
J Nutr Biochem
Lombardi VC, De Meirleir KL, Subramanian K, Nourani SM, Dagda RK, Delaney SL, Palotás A
This study was a review of select neurological diseases and evidence pointing the impact of the gut microbiome on disease development. Authors also discuss how nutrition can change the microbiome to affect disease outcomes.
Key Findings: Neurological diseases (including Parkinsons, Alzheimer's, Autism, Mutliple Sclerosis, and Schizophrenia) are associated with the gut microbiome compositon. Nutrition has been found to affect biomarkers of these diseases in the gut. Compounds found in peanuts, including polyphenols and stillbenes (resveratrol), omega fats, and B-vitamins, have all been found to affect disease development through the gut microbiome. Some of these findings are in the beginning stages, so there is a need for more research to address this.